Nanoengineered Drug Combinations for Breast Cancer Treatment

Abstract

Nanoparticles can be used to enhance the efficacy of chemotherapeutic drugs while minimizing their side effects. This project aims to utilize nanoparticles for effective delivery of two therapeutic agents. In particular, we aim to use two breast cancer drugs which enhance each other's efficacy (synergistic drugs), and use them as a model drug pair for the development of a novel dual-drug nano-therapeutic system. The research to date on the project has been focused on screening and identification of drug combinations that exhibit synergistic effect in vitro. This report summarizes these studies and the progress to date.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jun 01, 2012
Accession Number
ADA581573

Entities

People

  • Samir Mitragotri

Organizations

  • University of California, Santa Barbara

Tags

DTIC Thesaurus Topics

  • Biomedical Research
  • Breast Cancer
  • Cell Line
  • Cells
  • Chemical Engineering
  • Combination Therapy
  • Cytotoxins
  • Department Of Defense
  • Diseases And Disorders
  • Drug Combinations
  • Drug Resistance
  • Engineering
  • Incubation
  • Nanoparticles
  • Neoplasms
  • Particles
  • Simulations

Fields of Study

  • Biology
  • Chemistry
  • Medicine

Readers

  • Oncology (Cancer Research).

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech